{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T02:14:25Z","timestamp":1771640065744,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","jocn-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jocn.2017.10.077","type":"journal-article","created":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T22:30:21Z","timestamp":1509748221000},"page":"102-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Mycosis fungoides \u2013 A cutaneous lymphoproliferative disorder in a patient treated with fingolimod for multiple sclerosis"],"prefix":"10.1016","volume":"48","author":[{"given":"Zeev","family":"Nitsan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nihal","family":"Kucuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shmuel","family":"Appel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Tichmanovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Osherov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Milo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2017.10.077_b0005","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa052643","article-title":"Oral fingolimod (FTY720) for relapsing multiple sclerosis","volume":"355","author":"Kappos","year":"2006","journal-title":"N Eng J Med"},{"key":"10.1016\/j.jocn.2017.10.077_b0010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/1352458515597568","article-title":"Lymphomatoid papulosis: a cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis","volume":"22","author":"Samaraweera","year":"2006","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2017.10.077_b0015","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1177\/1352458516642032","article-title":"Lymphomatoid papulosis type D in a fingolimod-treated multiple sclerosis patient","volume":"22","author":"Matoula","year":"2016","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2017.10.077_b0020","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1177\/1352458516639759","article-title":"Lymphomatoid papulosis and fingolimod \u2013 A new connection?","volume":"22","author":"Cohen","year":"2016","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2017.10.077_b0025","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1177\/1352458516645868","article-title":"Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod","volume":"22","author":"Papathemeli","year":"2016","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2017.10.077_b0030","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.msard.2014.03.002","article-title":"Fingolimod in relapsing multiple sclerosis: an integrated analysis of safety findings","volume":"3","author":"Kappos","year":"2014","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jocn.2017.10.077_b0035","unstructured":"Gilenya Summary of Product Information. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002202\/WC500104528.pdf (Accessed 25 December 2016)"},{"key":"10.1016\/j.jocn.2017.10.077_b0040","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1474-4422(14)70049-3","article-title":"Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomized, placebo-controlled, Phase 3 trial","volume":"13","author":"Calabresi","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2017.10.077_b0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2014.03.007","article-title":"FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway","volume":"270","author":"Ntranos","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jocn.2017.10.077_b0050","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2230.2008.03024.x","article-title":"Lymphomatoid papulosis and associated lymphomas: a retrospective case series of 84 patients","volume":"34","author":"Kunishige","year":"2009","journal-title":"Clin Exp Dermatol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586817311098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586817311098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T09:03:13Z","timestamp":1535274193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586817311098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":10,"alternative-id":["S0967586817311098"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2017.10.077","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mycosis fungoides \u2013 A cutaneous lymphoproliferative disorder in a patient treated with fingolimod for multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2017.10.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}